Erste Asset Management GmbH Raises Holdings in Masimo Corporation $MASI

Key Points

• Erste Asset Management GmbH increased its stake in Masimo Corporation by 11.3%, holding a total of 92,000 shares valued at approximately $15.33 million.
• Masimo reported earnings per share of $1.33 for the recent quarter, surpassing analyst estimates and showcasing a 7.7% year-over-year revenue growth.
• Institutional investors and hedge funds collectively own over 85% of Masimo's stock, indicating strong institutional interest in the company.

Erste Asset Management GmbH grew its position in shares of Masimo Corporation (NASDAQ:MASI - Free Report) by 11.3% in the first quarter, according to its most recent filing with the SEC. The fund owned 92,000 shares of the medical equipment provider's stock after acquiring an additional 9,348 shares during the quarter. Erste Asset Management GmbH owned about 0.17% of Masimo worth $15,327,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the stock. Farther Finance Advisors LLC lifted its position in Masimo by 128.9% in the first quarter. Farther Finance Advisors LLC now owns 206 shares of the medical equipment provider's stock worth $35,000 after buying an additional 116 shares during the last quarter. NBC Securities Inc. bought a new stake in Masimo in the first quarter worth $61,000. UMB Bank n.a. lifted its position in Masimo by 134.0% in the first quarter. UMB Bank n.a. now owns 447 shares of the medical equipment provider's stock worth $74,000 after buying an additional 256 shares during the last quarter. GAMMA Investing LLC lifted its position in Masimo by 58.4% in the first quarter. GAMMA Investing LLC now owns 738 shares of the medical equipment provider's stock worth $123,000 after buying an additional 272 shares during the last quarter. Finally, BI Asset Management Fondsmaeglerselskab A S bought a new stake in Masimo in the fourth quarter worth $163,000. 85.96% of the stock is currently owned by institutional investors.

Insider Activity at Masimo

In other news, Director William R. Jellison bought 3,000 shares of the firm's stock in a transaction that occurred on Monday, August 11th. The stock was purchased at an average price of $145.98 per share, with a total value of $437,940.00. Following the completion of the acquisition, the director directly owned 4,790 shares of the company's stock, valued at $699,244.20. This trade represents a 167.60% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 16.90% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the company. Piper Sandler raised their price target on Masimo from $200.00 to $210.00 and gave the stock an "overweight" rating in a research report on Wednesday, August 6th. BTIG Research reiterated a "buy" rating on shares of Masimo in a research report on Thursday, August 14th. Wall Street Zen downgraded Masimo from a "buy" rating to a "hold" rating in a research report on Friday, May 30th. Raymond James Financial decreased their target price on Masimo from $204.00 to $185.00 and set an "outperform" rating for the company in a research report on Wednesday, May 7th. Finally, Wells Fargo & Company decreased their target price on Masimo from $205.00 to $190.00 and set an "overweight" rating for the company in a research report on Wednesday, May 7th. Five investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $193.60.

Masimo Stock Down 0.7%

Shares of Masimo stock traded down $1.03 during trading on Tuesday, hitting $144.12. 89,173 shares of the stock traded hands, compared to its average volume of 630,396. The firm has a market cap of $7.83 billion, a P/E ratio of -16.93 and a beta of 1.21. The company has a current ratio of 2.14, a quick ratio of 1.61 and a debt-to-equity ratio of 0.57. Masimo Corporation has a 52-week low of $107.98 and a 52-week high of $194.88. The stock's fifty day simple moving average is $158.85 and its 200 day simple moving average is $162.54.

Masimo (NASDAQ:MASI - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The medical equipment provider reported $1.33 EPS for the quarter, beating the consensus estimate of $1.22 by $0.11. Masimo had a positive return on equity of 26.54% and a negative net margin of 24.85%.The firm had revenue of $370.90 million for the quarter, compared to analyst estimates of $368.65 million. During the same quarter last year, the firm posted $0.86 earnings per share. The business's revenue for the quarter was up 7.7% on a year-over-year basis. On average, equities analysts predict that Masimo Corporation will post 4.1 earnings per share for the current fiscal year.

Masimo Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.